INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›business›Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
business

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

By Info60 UK Desk•Summary of reporting by Pr Newswire Uk•Sep 21, 2026•0 views•
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive...
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

The AI telling farmers when to harvest

The AI telling farmers when to harvest

BBC Business

Vape prices to rise as new tax takes effect

Vape prices to rise as new tax takes effect

BBC Business

Energy bills are going up - here's what you can do about it

Energy bills are going up - here's what you can do about it

BBC Business

Flydubai passenger describes putting attacker in chokehold after cockpit stabbing

Flydubai passenger describes putting attacker in chokehold after cockpit stabbing

yahoo.com

FTC opens probe into AI giants including Anthropic and OpenAI

FTC opens probe into AI giants including Anthropic and OpenAI

Reuters

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!